Business Description
Sagimet Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US7867001049
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7450.19 | |||||
Equity-to-Asset | 0.98 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 20.18 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -78.9 | |||||
3-Year EPS without NRI Growth Rate | -73.1 | |||||
3-Year FCF Growth Rate | -69.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.65 | |||||
9-Day RSI | 38.09 | |||||
14-Day RSI | 43.72 | |||||
6-1 Month Momentum % | 12.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 43.12 | |||||
Quick Ratio | 43.12 | |||||
Cash Ratio | 42.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | -65.94 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1637.15 | |||||
Net Margin % | -1395.9 | |||||
FCF Margin % | -1127.05 | |||||
ROA % | -31.52 | |||||
ROIC % | -10000.92 | |||||
ROC (Joel Greenblatt) % | -30261.55 | |||||
ROCE % | -39.25 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 45.64 | |||||
PB Ratio | 0.84 | |||||
Price-to-Tangible-Book | 0.75 | |||||
EV-to-EBIT | 1.39 | |||||
EV-to-EBITDA | 1.39 | |||||
EV-to-Revenue | -22.85 | |||||
EV-to-FCF | 1.46 | |||||
Price-to-Net-Current-Asset-Value | 0.75 | |||||
Price-to-Net-Cash | 0.75 | |||||
Earnings Yield (Greenblatt) % | 71.81 | |||||
FCF Yield % | -15.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sagimet Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.874 | ||
EPS (TTM) (€) | -1.148 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 43.72 | ||
14-Day ATR (€) | 0.198896 | ||
20-Day SMA (€) | 4.4045 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 2.04 - 16.7 | ||
Shares Outstanding (Mil) | 31.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sagimet Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sagimet Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Sagimet Biosciences Inc Frequently Asked Questions
What is Sagimet Biosciences Inc(STU:0O2)'s stock price today?
When is next earnings date of Sagimet Biosciences Inc(STU:0O2)?
Does Sagimet Biosciences Inc(STU:0O2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |